Administration of metyrapone via nasogastric tube in a critically ill patient: A case report - 23/09/26
Doi : 10.1016/j.ando.2026.103096
Lucia Bedatsova 1, #, Marine Mondon 2, #, Emmanuele Guignard 3, Nawfel Ben-Hamouda 4, 5, Georgios E. Papadakis 1, 5, ⁎ 
1 Division of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne, 1011 Lausanne, Switzerland
2 Department of Internal Medicine, University Hospital of Lausanne, 1011 Lausanne, Switzerland
3 Pharmacy Department, University Medical Outpatient Clinic, University Hospital of Lausanne, 1011 Lausanne, Switzerland
4 Department of Adult Intensive Care Medicine, University Hospital of Lausanne, 1011 Lausanne, Switzerland
5 Faculty of Biology and Medicine, University of Lausanne, 1015, Lausanne, Switzerland
⁎ Corresponding author: Division of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne, 1011 Lausanne, Switzerland Division of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne Lausanne 1011 Switzerland
Sous presse. Manuscrit accepté.
Disponible en ligne depuis le Wednesday 23 September 2026
Keywords : metyrapone, cortisol, Cushing’s syndrome, nasogastric tube, intensive care
Le texte complet de cet article est disponible en PDF.
© 2026
Publié par Elsevier Masson SAS.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?